NYSE · Medical - Devices

AVNS (AVNS) Stock

$24.99 +0.04% NYSE: AVNS Healthcare

Valuation

MetricValue
Price$24.99
Market Cap$1.17B
P/E Ratio19.96
P/B Ratio1.49
P/S Ratio1.63
EPS (TTM)$0.00
52-Week High$25.49
52-Week Low$9.30
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-9.18%
ROA0.95%
ROCE-7.97%
Gross Margin48.55%
Operating Margin-7.92%
Net Margin-9.69%
Debt/Equity0.18
Current Ratio2.15

Annual Financials (USD)

Metric20212022202320242025
Revenue$745.0M$684.0M$673.0M$688.0M$701.0M
Operating Profit$87.0M$42.0M$65.0M$40.0M$-62.0M
Net Profit$6.0M$51.0M$-62.0M$-392.0M$-68.0M
EPS$0.13$1.07$-1.33$-8.53$-1.46
Op Margin11.7%6.1%9.7%5.8%-8.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.6B$1.8B$1.7B$1.2B$1.1B
Total Liabilities$333.0M$496.0M$456.0M$326.0M$296.0M
Cash$119.0M$128.0M$88.0M$108.0M$90.0M
Borrowings$188.0M$277.0M$209.0M$170.0M$129.0M

Latest News

AVNS: What does Argus have to say about AVNS? Argus Research · Jul 15, 2026 Avanos, American Industrial Get Regulatory Approval for Merger MT Newswires · Jul 2, 2026 Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger PR Newswire · Jul 2, 2026 Tactile Systems Technology (TCMD) Moves 8.1% Higher: Will This Strength Last? Zacks · Jun 29, 2026 Reasons to Retain Avanos Medical Stock in Your Portfolio for Now Zacks · Jun 24, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$87.0M$91.0M$32.0M$101.0M$75.0M
Investing Cash Flow$-42.0M$-155.0M$4.0M$-45.0M$-92.0M
Financing Cash Flow$-5.0M$-47.0M$-29.0M$-15.0M$-3.0M
Net Cash Flow$7.0M$9.0M$-40.0M$20.0M$-18.0M
Free Cash Flow$66.0M$72.0M$15.0M$83.0M$43.0M

Valuation & Return Ratios

MetricValue
PEG Ratio24.14
EV / EBITDA22.21
FCF Yield0.64%
Quick Ratio1.40
Interest Coverage-15.50
Return 1Y106.28%
Return 3Y-2.19%
Return 5Y-27.63%

Ownership

Insiders Held3.28%
Institutions Held92.74%
Institutions Float Held95.89%
Institutional HolderSharesReport Date
Blackrock Inc.6,843,7332026-03-31
T. Rowe Price Investment Management, Inc.5,330,7762026-03-31
Brown Advisory Inc.2,231,1982026-03-31
Dimensional Fund Advisors LP2,052,3562026-03-31
Armistice Capital, LLC2,000,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About AVNS

AVNS is led by CEO David C. Pacitti, employs 2,227 people, headquartered in US, publicly traded since 2014.

AVNS stock trades at $24.99 with a market capitalization of $1.17B. The stock is valued at a price-to-earnings (P/E) ratio of 19.96, price-to-book of 1.49, price-to-sales of 1.63. Over the past 52 weeks the stock has ranged between $9.30 and $25.49, and currently trades 2.0% below its 52-week high.

On profitability, AVNS generates a return on equity (ROE) of -9.18%, return on capital employed of -7.97%, an operating margin of -7.92%, a net profit margin of -9.69%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides